AbbVie subsidiary Forest faces more antitrust litigation over Alzheimer’s drug as judge rejects its bid to toss case kdunleavy Mon, 06/14/2021 – 11:49 More: AbbVie subsidiary Forest faces more antitrust litigation over Alzheimer's drug as judge rejects its bid to
read moreBiogen’s $56K price on Aduhelm ‘simply unacceptable,’ Alzheimer’s Association says after vouching for FDA approval nhigginsdunn Mon, 06/14/2021 – 11:16 More: Biogen's K price on Aduhelm 'simply unacceptable,' Alzheimer's Association says after vouching for FDA approval Source: fierce
read moreHow did 75 million J&J vaccines get ruined? FDA details the manufacturing woes at Emergent’s beleaguered site fkansteiner Mon, 06/14/2021 – 10:37 More: How did 75 million J&J vaccines get ruined? FDA details the manufacturing woes at Emergent's beleaguered site
read moreAstraZeneca, Daiichi Sankyo launch Enhertu head-to-head trial with eyes on a new breast cancer standard aliu Mon, 06/14/2021 – 09:55 More: AstraZeneca, Daiichi Sankyo launch Enhertu head-to-head trial with eyes on a new breast cancer standard Source: fierce
read moreVerona sells Chinese rights to inhaled drug for $40M upfront ntaylor Mon, 06/14/2021 – 07:44 More: Verona sells Chinese rights to inhaled drug for M upfront Source: fierce
read moreImmunotherapy combo approved for the treatment of advanced bowel cancer patients with rare MSI-H/dMMR mutations More: Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals